Court Approves Bayer’s $7.25B Roundup Settlement

Final approval of Bayer’s class action settlement of current and future glyphosate-related non-Hodgkin’s lymphoma claims follows June’s Supreme Court ruling on Roundup labeling.

Spraying post emergence by Lindsey Pound
(Lindsey Pound)

On Nov. 20, another milestone was reached in the ongoing legal cases regarding glyphosate. A Missouri state court granted final approval of Monsanto’s $7.25 billion nationwide class settlement of Roundup claims alleging non-Hodgkin’s lymphoma (NHL), Bayer said in a statement. The company says the settlement is designed to resolve current and future claims through a long-term claims program.

Bayer CEO Bill Anderson called final approval “a decisive milestone” in the company’s strategy to mitigate the risk of both pending and future Roundup litigation. Bayer, which acquired Monsanto in 2018, describes the settlement and the Supreme Court’s June ruling as “mutually reinforcing pillars” of that strategy.

In a statement from Monsanto, the company said: “Today, a Missouri state court granted final approval of the U.S. nationwide class settlement designed to resolve current and future Roundup claims alleging non-Hodgkin’s lymphoma (NHL) injuries through a long-term claims program. The class settlement, combined with the U.S. Supreme Court’s favorable ruling in June in the Durnell case, are mutually reinforcing pillars in the company’s multipronged strategy designed to significantly contain the Roundup litigation.”

“The Court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” said Bill Anderson, CEO at Bayer.

The settlement covers people exposed to Roundup or other glyphosate-based products before Feb. 17, 2026, including farmers, landscapers and groundskeepers. Per-claimant payouts depend on exposure type, age at diagnosis and NHL type, and Monsanto funds the deal over 17 to 21 years. Bayer does not admit liability, and says the weight of scientific evidence supports glyphosate’s safety when used as directed.

Christopher A. Seeger of Seeger Weiss, counsel for current claimants in the settlement, has called it “one of the largest class recoveries in U.S. history.”

The approval is the latest in a run of wins for Monsanto this year:

  • June 25: In Monsanto v. Durnell, the Supreme Court ruled 7-2 that federal pesticide law (FIFRA) preempts state failure-to-warn claims that would require a cancer warning EPA has not required.
  • Oct. 29: A St. Louis County jury returned a unanimous defense verdict in Aretino v. Monsanto, the first Roundup trial since Durnell. With failure-to-warn claims barred, plaintiffs pursued design defect, fraud and negligence, and lost on all three.
Scoop-logo (1346x354)
Read Next
High costs and tight margins mean another tough year. The October Ag Economists Monthly Monitor warns of a growing gap between financially strong farms and those lacking resources to survive the prolonged downturn.
Follow the Scoop
Get Daily News
Get Markets Alerts
Get News & Markets App